RTMS for the Treatment of Post-COVID Associated Affective Symptoms
RecruitingNCT06716996Phase: NAStarted 2024-11-14
Summary
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) can lead to major post-acute sequelae. It is estimated that over 60 million people worldwide are affected by this multisystemic condition,
Eligibility
Sex
ALL
Min Age
18 Years
Max Age
65 Years
Locations
Psychiatric University Hospital ZurichZurich, Canton of Zurich, Switzerland
View full study details on ClinicalTrials.gov
clinicaltrials.gov/study/NCT06716996